SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

PROGEN PHARMACEUTICALS LIMITED (PGL)

Former Name ASX

SHARE PRICES

Former (or subsequent) names

Shareholder links

Our website ranking of PGL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Investor Services, Level 11 172 St Georges Terrace Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

Address: Level 18, 101 Collins Street Melbourne VIC 3000
Tel:  +61-7-3273 9133 Fax: +61-7-3375 1168

Date first listed: 22/12/1995
Company Secretary: Mr Blair Lucas
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research & development of potential biopharmaceutical therapeutics for the treatement of human diseases; development, manufacture, importation & distribution of a range of molecular biology products, consumables & fine chemicals for the scientific researc

name changed to TBG Diagnostics Limited

02/02/2016

The company provides the following update: the company is working towards a relisting date of 3 February, 2016; the company has completed the acquisition of TBG Inc.; it has received valid applications for a total of 60,579,000 new shares which represents a total raising of $12,721,590 which were issued to investors pursuant to the terms of the offer under the prospectus; company will change its ASX code; and it has also provided an indicative timetable.

29/01/2016

TBG Diagnostics Limited (formerly Progen Pharmaceuticals Ltd) advises that the following unlisted options issued under the Company's Employee Share Option Plan have lapsed: Number: 90,000 Exercise Price: $0.29 Expiry: 1 January 2016

29/01/2016

The company is pleased to announce that the Company has received valid applications for a total of 69,579,000 new shares under the Prospectus dated 10 November 2015, which represents a total raising of $12,721,590.

11/12/2015

The securities of Progen Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, following receipt of security holder approval concerning a transaction which will result in a significant change to the Company's scale. The Company's securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3. Security Code: PGL

07/12/2015

name changed from Progen Industries Limited

02/04/2007

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    14/05/2014Jitto Arulampalam40,000$1.010$40,398
    12/03/2014Heng Tang10,000$0.520$5,200
    12/12/2013Heng Tang10,000$0.220$2,196
    06/12/2013Heng Tang33,000$0.227$7,475
    26/03/2013Woei-Jia Jiang13,389$0.230$3,079

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jitto ArulampalamNon Exec Chairman12/06/2013
    Emily LeeDirector07/12/2015
    Eugene ChengDirector07/12/2015
    Stanley ChangDirector07/12/2015

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Christopher HarveyIndependent Director16/03/201507/12/2015
    Hongjen ChangNon Exec Director29/11/201307/12/2015
    Heng TangManaging Director, CEO17/07/200916/03/2015
    Stuart JamesNon Exec Chairman01/07/200928/11/2013
    Woei-Jia JiangDirector16/06/201112/07/2013
    Paul DixonCFO03/04/200912/10/2012
    Thomas BurtNon Exec Director17/07/200930/11/2011
    Sue MacLemanCEO06/04/201026/08/2011

    Date of first appointment, title may have changed.